SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-16-011128
Filing Date
2016-04-29
Accepted
2016-04-29 17:24:18
Documents
2
Period of Report
2016-04-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-35226.html 3  
1 PRIMARY DOCUMENT marketforms-35226.xml 3 4189
2 POA DOCUMENT poa.htm EX-24 3918
  Complete submission text file 0001214659-16-011128.txt   9486
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THE MEDICINES COMPANY 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
Furse Brent (Reporting) CIK: 0001600752 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34637 | Film No.: 161608506